The Turkish Green Crescent Society (Yeşilay) has disseminated a comprehensive report detailing the prevalence, initiation factors, and physiological consequences of alcohol consumption within the Turkish population.

土耳其綠新月會 (Yeşilay) 發布了一份詳盡報告，詳細闡述了土耳其人口中酒精消費的盛行率、觸發因素及其生理後果。

The Türkiye Alcohol Research Report indicates that 20.8% of individuals aged 15 and older have consumed alcohol at least once, while 79.2% remain abstinent. Temporal data reveals that 11.4% of the population engaged in alcohol use within the preceding twelve months, with 7.1% doing so within the last thirty days. The prevalence of alcohol use disorders is estimated at 4.8% domestically, aligning with a global context where approximately 400 million individuals are affected.

土耳其酒精研究報告指出，15 歲及以上的人群中，有 20.8% 至少飲酒一次，而 79.2% 保持禁酒。時間數據顯示，過去 12 個月內有 11.4% 的人口飲酒，過去 30 天內則有 7.1% 飲酒。國內酒精使用失調的盛行率估計為 4.8%，與全球約 4 億人受影響的情況一致。

Regarding the onset of consumption, the mean age of first use is 19.4 years; however, 50% of users initiated consumption by age 18. The primary catalysts for this initiation are identified as peer influence (48.8%), entertainment objectives (45.4%), and curiosity (43.6%). Dr. Mehmet Dinç of Yeşilay posits that the societal normalization of alcohol obscures its status as a significant social risk and a preventable catalyst for mortality.

關於飲酒起始年齡，平均首次飲酒年齡為 19.4 歲；然而，50% 的使用者在 18 歲前就已開始飲酒。觸發起始的主要因素為同儕影響 (48.8%)、娛樂目的 (45.4%) 以及好奇心 (43.6%)。Yeşilay 的 Mehmet Dinç 醫生認為，社會對酒精的常態化掩蓋了其作為重大社會風險及可預防死亡誘因的地位。

Clinical assessments provided by Dr. Ayşe Nurdan Tözün emphasize the systemic pathology associated with ethanol. The liver, performing over 500 metabolic functions, is particularly susceptible, progressing from asymptomatic fatty liver disease to fibrosis in 20% to 40% of cases, and potentially advancing to cirrhosis or hepatocellular carcinoma. Dr. Tözün notes that in Europe, nearly 50% of liver transplants are necessitated by alcohol-related pathologies. Furthermore, the intersection of adolescent alcohol use and obesity is identified as a critical risk factor for long-term health deterioration. In accordance with evolving international medical guidelines, the threshold for safe consumption is now characterized as zero.

Ayşe Nurdan Tözün 醫生提供的臨床評估強調了與乙醇相關的系統性病理。肝臟執行超過 500 種代謝功能，極易受損，在 20% 至 40% 的病例中會從無症狀脂肪肝發展至纖維化，並可能進展為肝硬化或肝細胞癌。Tözün 醫生指出，在歐洲，近 50% 的肝臟移植是由於酒精相關病理所需。此外，青少年飲酒與肥胖的交集被視為長期健康惡化的關鍵風險因素。根據演進中的國際醫學指南，安全飲酒的閾值現在被定義為零。

The current situation is characterized by a documented prevalence of early-onset alcohol use and a corresponding public health burden, addressed by Yeşilay through its nationwide network of counseling centers.

目前的狀況是以酒精使用起始年齡提前以及相應的公共健康負擔為特徵，Yeşilay 正透過其全國性的諮詢中心網絡來應對此問題。